Great insight. From someone who is not all that knowledgeable in this area, I wonder why the first two attempts didn’t work out? I believe an RS would be toxic for shareholders unless a PR happens beforehand that brings on more investors. I understand how the “prudent person” rule limits big money from entering at these prices, however it’s unreasonable to think that an RS will bring value to a company or investors without preparation before hand……maybe they have started preparing and they have big news to drop but are lining up ducks for an uplisting/buyout search.
If that’s the case I would first expect to see 1) PR for the PRP study 2) RS 3) PR for Uplisting plan/Roadmap.
Feel free to destroy this post, just looking at it from a low experience point of view.